Search results for "Bio"

Suspected Pancreatic Cancer Once Meant a Two-Night Stay. Asan Medical Center Cuts It to One Day

Suspected Pancreatic Cancer Once Meant a Two-Night Stay. Asan Medical Center Cuts It to One Day

When patients are told something looks abnormal in their pancreas, many begin worrying about hospital admission even before receiving test results.
Low Levels of Muscle Protein 'Irisin' Linked to Early Alzheimer's Risk Before Memory Loss

Low Levels of Muscle Protein 'Irisin' Linked to Early Alzheimer's Risk Before Memory Loss

Could a simple blood test identify people who show no memory loss but already have Alzheimer's-related protein buildup in their brain.
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation

KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation

Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market

Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market

Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...
Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.

Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.

Daewoong Pharmaceutical announced on July 23 that it has severed supply transactions with a domestic medical...
Samsung Biologics Posts 586.4 Billion Won Q2 Profit, But Labor Uncertainty Looms

Samsung Biologics Posts 586.4 Billion Won Q2 Profit, But Labor Uncertainty Looms

Samsung Biologics reported second-quarter revenue in the 1.3 trillion won range this year, a 30% increase from the same...